Interleukin-2 in Metastatic Melanoma

Clinical trial NCT01702896 · TERMINATED

Trial details

NCT number: NCT01702896
Sponsor: Western Regional Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Metastatic

Start date: 2012-09-01
Primary completion: 2014-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.